Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cyclic AMP receptor protein (CRP), also known as catabolite activator protein (CAP), is a global transcription regulator in bacteria, notably Escherichia coli[4][9]. Upon binding cyclic AMP (cAMP), CRP undergoes an allosteric conformational change that enables it to bind specific DNA sites at promoters of various genes[7][9]. This interaction facilitates the recruitment of RNA polymerase and the activation of transcription for genes mainly involved in bacterial energy metabolism, including pathways using alternative carbon sources when glucose is scarce[4][9]. The CRP/cAMP system is not a therapeutic target in human medicine, but it is a well-characterized model for bacterial gene regulation and signal transduction[4][9]. CRP has no direct role in human disease but is studied for broader insights into gene activation and metabolic control mechanisms.
Not a direct target of any therapeutic agent; functions as a regulator in response to intracellular cAMP.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cyclic AMP receptor protein (CRP).